Cited by 617SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studies

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis

Open access
Sun, Shi-Hui, Chen, Qi, Gu, Hong-Jing, Yang, Guan, Wang, Yan-Xiao, Huang, Xing-Yao, Liu, Su-Su, Zhang, Na-Na +15 more·2020·Cell Host & Microbe

Abstract

Since December 2019, a novel coronavirus SARS-CoV-2 has emerged and rapidly spread throughout the world, resulting in a global public health emergency. The lack of vaccine and antivirals has brought an urgent need for an animal model. Human angiotensin-converting enzyme II (ACE2) has been identified as a functional receptor for SARS-CoV-2. In this study, we generated a mouse model expressing human ACE2 (hACE2) by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young and aged hACE2 mice sustained high viral loads in lung, trachea, and brain upon intranasal infection. Although fatalities were not observed, interstitial pneumonia and elevated cytokines were seen in SARS-CoV-2 infected-aged hACE2 mice. Interestingly, intragastric inoculation of SARS-CoV-2 was seen to cause productive infection and lead to pulmonary pathological changes in hACE2 mice. Overall, this animal model described here provides a useful tool for studying SARS-CoV-2 transmission and pathogenesis and evaluating COVID-19 vaccines and therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chom.2020.05.020

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The ACE2 receptor is significantly different between mice and humans; so mouse models most often use a humanized ACE2 or lung passage to overcome this obstacle.

    “Although mouse models have the most information available about their biology and many research tools, the ACE2 receptor is significantly different between mice and humans; so mouse models most often use a humanized ACE2 or lung passage to overcome this obstacle. 177-179”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [178]

    The Introduction and Results (pages not provided) describe replacing mouse ACE2 with human ACE2 to create a SARS-CoV-2 mouse model, supporting humanization as one approach. The passages do not establish that the receptors are significantly different or that mouse models most often use either humanized ACE2 or lung passage; lung passage is not described. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Investigators found viral replication in a number of organs with the highest expression in the lung and brain and increased serum cytokines including IFNγ; however, the mouse background used in these models was C57BL/6, which responds to antigens with elevated Th1-type immune responses because they have few mast cells.

    “Investigators found viral replication in a number of organs with the highest expression in the lung and brain and increased serum cytokines including IFN γ ; however, the mouse background used in these models was C57BL/6, which responds to antigens with elevated Th1-type immune responses because they have few mast cells. 160,177,178”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [178]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. Bao L. Deng W. Huang B. Gao H. Liu J. Ren L. Wei Q. Yu P. Xu Y. Qi F. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice Nature 2020 32380511
  2. Cai J. Xu J. Lin D. Yang Z. Xu L. Qu Z. Zhang Y. Zhang H. Jia R. Liu P. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features Clin. Infect. Dis. 2020 10.1093/cid/ciaa198 ciaa198 PMC7108143 32112072 · DOI
  3. Chan K.H. Peiris J.S. Lam S.Y. Poon L.L. Yuen K.Y. Seto W.H. The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus Adv. Virol. 2011 2011 10.1155/2011/734690 734690 PMC3265313 22312351 · DOI
  4. Chen N. Zhou M. Dong X. Qu J. Gong F. Han Y. Qiu Y. Wang J. Liu Y. Wei Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 395 2020 507 513 32007143 PMC7135076
  5. Cui J. Li F. Shi Z.L. Origin and evolution of pathogenic coronaviruses Nat. Rev. Microbiol. 17 2019 181 192 30531947 PMC7097006
  6. Du L. He Y. Zhou Y. Liu S. Zheng B.J. Jiang S. The spike protein of SARS-CoV--a target for vaccine and therapeutic development Nat. Rev. Microbiol. 7 2009 226 236 19198616 PMC2750777
  7. Haagmans B.L. Kuiken T. Martina B.E. Fouchier R.A. Rimmelzwaan G.F. van Amerongen G. van Riel D. de Jong T. Itamura S. Chan K.H. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques Nat. Med. 10 2004 290 293 14981511 PMC7095986
  8. Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Zhang L. Fan G. Xu J. Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 2020 497 506 31986264 PMC7159299
  9. Jin X. Lian J.S. Hu J.H. Gao J. Zheng L. Zhang Y.M. Hao S.R. Jia H.Y. Cai H. Zhang X.L. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms Gut 69 2020 1002 1009 32213556 PMC7133387
  10. Lan J. Ge J. Yu J. Shan S. Zhou H. Fan S. Zhang Q. Shi X. Wang Q. Zhang L. Wang X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Nature 581 2020 215 220 32225176
  11. Li W. Moore M.J. Vasilieva N. Sui J. Wong S.K. Berne M.A. Somasundaran M. Sullivan J.L. Luzuriaga K. Greenough T.C. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 2003 450 454 14647384 PMC7095016
  12. Lin L. Jiang X. Zhang Z. Huang S. Zhang Z. Fang Z. Gu Z. Gao L. Shi H. Mai L. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection Gut 69 2020 997 1001 32241899
  13. Lu R. Zhao X. Li J. Niu P. Yang B. Wu H. Wang W. Song H. Huang B. Zhu N. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet 395 2020 565 574 32007145 PMC7159086
  14. McCray P.B. Jr. Pewe L. Wohlford-Lenane C. Hickey M. Manzel L. Shi L. Netland J. Jia H.P. Halabi C. Sigmund C.D. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus J. Virol. 81 2007 813 821 17079315 PMC1797474
  15. Monteil V. Kwon H. Prado P. Hagelkrüys A. Wimmer R.A. Stahl M. Leopoldi A. Garreta E. Hurtado Del Pozo C. Prosper F. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 Cell 181 2020 905 913.e7 32333836 PMC7181998
  16. Ou X. Liu Y. Lei X. Li P. Mi D. Ren L. Guo L. Guo R. Chen T. Hu J. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV Nat. Commun. 11 2020 1620 32221306 PMC7100515
  17. Peiris J.S. Lai S.T. Poon L.L. Guan Y. Yam L.Y. Lim W. Nicholls J. Yee W.K. Yan W.W. Cheung M.T. SARS study group Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 2003 1319 1325 12711465 PMC7112372
  18. Shang J. Ye G. Shi K. Wan Y. Luo C. Aihara H. Geng Q. Auerbach A. Li F. Structural basis of receptor recognition by SARS-CoV-2 Nature 581 2020 221 224 32225175 PMC7328981
  19. Tseng C.T. Huang C. Newman P. Wang N. Narayanan K. Watts D.M. Makino S. Packard M.M. Zaki S.R. Chan T.S. Peters C.J. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor J. Virol. 81 2007 1162 1173 17108019 PMC1797529
  20. van den Brand J.M. Stittelaar K.J. van Amerongen G. Rimmelzwaan G.F. Simon J. de Wit E. Munster V. Bestebroer T. Fouchier R.A. Kuiken T. Osterhaus A.D. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus J. Infect. Dis. 201 2010 993 999 20187747 PMC7110095
  21. van Doremalen N. Bushmaker T. Munster V.J. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions Euro Surveill. 18 2013 20590 24084338
  22. Walls A.C. Park Y.-J. Tortorici M.A. Wall A. McGuire A.T. Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Cell 181 2020 281 292.e6 32155444 PMC7102599
  23. Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. Wang B. Xiang H. Cheng Z. Xiong Y. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China JAMA 2020 10.1001/jama.2020.1585 PMC7042881 32031570 · DOI · Paper page
  24. Xu Y. Li X. Zhu B. Liang H. Fang C. Gong Y. Guo Q. Sun X. Zhao D. Shen J. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding Nat. Med. 26 2020 502 505 32284613 PMC7095102
  25. Yang X.H. Deng W. Tong Z. Liu Y.X. Zhang L.F. Zhu H. Gao H. Huang L. Liu Y.L. Ma C.M. Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection Comp. Med. 57 2007 450 459 17974127
  26. Yang X. Yu Y. Xu J. Shu H. Xia J. Liu H. Wu Y. Zhang L. Yu Z. Fang M. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir. Med. 8 2020 475 481 32105632 PMC7102538
  27. Yeo C. Kaushal S. Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol. Hepatol. 5 2020 335 337 32087098 PMC7130008
  28. Zaki A.M. van Boheemen S. Bestebroer T.M. Osterhaus A.D. Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia N. Engl. J. Med. 367 2012 1814 1820 23075143
  29. Zhou F. Yu T. Du R. Fan G. Liu Y. Liu Z. Xiang J. Wang Y. Song B. Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 395 2020 1054 1062 32171076 PMC7270627
  30. Zhou P. Yang X.L. Wang X.G. Hu B. Zhang L. Zhang W. Si H.R. Zhu Y. Li B. Huang C.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 2020 270 273 32015507 PMC7095418
  31. Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. Zhao X. Huang B. Shi W. Lu R. China Novel Coronavirus Investigating and Research Team A Novel Coronavirus from Patients with Pneumonia in China, 2019 N. Engl. J. Med. 382 2020 727 733 31978945 PMC7092803
  32. Zou X. Chen K. Zou J. Han P. Hao J. Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection Front. Med. 14 2020 185 192 32170560 PMC7088738

Cited by

Sorted by citations

Authors
Sun, S.-H., Chen, Q., Gu, H.-J., Yang, G., Wang, Y.-X., Huang, X.-Y., Liu, S.-S., Zhang, N.-N., Li, X.-F., Xiong, R., Guo, Y., Deng, Y.-Q., Huang, W.-J., Liu, Q., Liu, Q.-M., Shen, Y.-L., Zhou, Y., Yang, X., Zhao, T.-Y., Fan, C.-F., Zhou, Y.-S., Qin, C.-F., & Wang, Y.-C.
Affiliations
  • Academy of Military Medical Sciences (CN)
  • Beijing Proteome Research Center (CN)
  • National Institutes for Food and Drug Control (CN)
  • Beijing Biocytogen (China) (CN)
Corresponding author
Zhou, Yu-Sen
Venue
Cell Host & Microbe
Publisher
Elsevier BV
Published
2020-07
Volume
28
Issue
1
Pages
124-133.e4
ISSN
1931-3128 (ISSN-L)
OpenAlex
W3031410383
Cited by
617
References
7
Citations by year
2026: 19 · 2025: 31 · 2024: 68 · 2023: 82 · 2022: 138 · 2021: 178 · 2020: 101
FWCI
16.47
Type
journal article
Language
en
Open access
Locations
  • Cell Host & Microbe (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Research and Development Project (2016YFD0500304, 2020YFA0707801)
  • National Science and Technology Major Project (2017ZX103304402, 2018ZX09711003)
  • National Natural Science Foundation (82041006, 31871476)
  • Guangdong Pearl River talent plan (2019CX01N111)
  • National Science Fund for Distinguished Young Scholar (81925025)
  • Innovative Research Group (81621005)
  • the Innovation Fund for Medical Sciences (2019-I2M-5-049)
  • Chinese Academy of Medical Sciences
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords
SARS-CoV-2, COVID-19 pandemic, mouse model, human ACE2, viral pathogenesis, viral load, interstitial lung disease, cytokines, aged mice, intragastric inoculation, intranasal infection, lung pathology, vaccine evaluation
MeSH terms
Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Aging, Animals, Brain, Disease Models, Animal, Peptidyl-Dipeptidase A, Lung, Mice, Inbred C57BL, Nose, Pneumonia, Viral, RNA, Viral, Stomach, Trachea, Virus Replication, Cytokines, Lung Diseases, Interstitial, Coronavirus Infections, Viral Load, Gene Knock-In Techniques, Pandemics, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review